Leptin-derived peptides that stimulate food intake and increase body weight following peripheral administration

Regulatory Peptides

Volumn 170, Issue 1-3, 2011, Pages 24-30

  Barrett, Graham L ^a   Naim, Tim ^a   Trieu, Jennifer ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Appetite; Hormone structure and function; Obesity; Peptide hormone receptor

Indexed keywords

APPETITE STIMULANT; LEPTIN; PEPTIDE [1-33]; PEPTIDE [61-90]; PHOSPHATE BUFFERED SALINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANOREXIA; APPETITE; ARTICLE; CACHEXIA; CONTROLLED STUDY; DRUG DOSE COMPARISON; FEMALE; FOOD INTAKE; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RAT; SEX DIFFERENCE; WEIGHT GAIN;

ANIMALS; DRUG EVALUATION, PRECLINICAL; EATING; FEMALE; LEPTIN; MALE; PEPTIDE FRAGMENTS; RATS; WEIGHT GAIN;

RATTUS;

EID: 79959707033     PISSN: 01670115     EISSN: 18731686     Source Type: Journal    
DOI: 10.1016/j.regpep.2011.05.004     Document Type: Article

References (44)

1. Harvey J., Ashford M.L. Leptin in the CNS: much more than a satiety signal. Neuropharmacology 2003, 44:845-854.
2. Bluher S., Mantzoros C.S. Leptin in humans: lessons from translational research. Am. J. Clin. Nutr. 2009, 89:991S-997S.
3. Farooqi I.S., O'Rahilly S. Leptin: a pivotal regulator of human energy homeostasis. Am. J. Clin. Nutr. 2009, 89:980S-984S.
4. Friedman J.M. Leptin at 14 y of age: an ongoing story. Am. J. Clin. Nutr. 2009, 89:973S-979S.
5. Peelman F., Waelput W., Iserentant H., Lavens D., Eyckerman S., Zabeau L., Tavernier J. Leptin: linking adipocyte metabolism with cardiovascular and autoimmune diseases. Prog. Lipid Res. 2004, 43:283-301.
6. Banks W.A. The many lives of leptin. Peptides 2004, 25:331-338.
7. Burguera B., Couce M.E. Leptin access into the brain: a saturated transport mechanism in obesity. Physiol. Behav. 2001, 74:717-720.
8. Kastin A.J., Pan W. Dynamic regulation of leptin entry into brain by the blood-brain barrier. Regul. Pept. 2000, 92:37-43.
9. Maffei M., Halaas J., Ravussin E., Pratley R.E., Lee G.H., Zhang Y., Fei H., Kim S., Lallone R., Ranganathan S., et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat. Med. 1995, 1:1155-1161.
10. Heymsfield S.B., Greenberg A.S., Fujioka K., Dixon R.M., Kushner R., Hunt T., Lubina J.A., Patane J., Self B., Hunt P., McCamish M. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. Jama 1999, 282:1568-1575.
11. Banks W.A., Farrell C.L. Impaired transport of leptin across the blood-brain barrier in obesity is acquired and reversible. Am. J. Physiol. Endocrinol. Metab. 2003, 285:E10-E15.
12. Myers M.G., Cowley M.A., Munzberg H. Mechanisms of leptin action and leptin resistance. Annu. Rev. Physiol. 2008, 70:537-556.
13. Barrett G.L., Trieu J., Naim T. The identification of leptin-derived peptides that are taken up by the brain. Regul. Pept. 2009, 155:55-61.
14. Iserentant H., Peelman F., Defeau D., Vandekerckhove J., Zabeau L., Tavernier J. Mapping of the interface between leptin and the leptin receptor CRH2 domain. J. Cell. Sci. 2005, 118:2519-2527.
15. Peelman F., Van Beneden K., Zabeau L., Iserentant H., Ulrichts P., Defeau D., Verhee A., Catteeuw D., Elewaut D., Tavernier J. Mapping of the leptin binding sites and design of a leptin antagonist. J. Biol. Chem. 2004, 279:41038-41046.
16. Zhang F., Basinski M.B., Beals J.M., Briggs S.L., Churgay L.M., Clawson D.K., DiMarchi R.D., Furman T.C., Hale J.E., Hsiung H.M., Schoner B.E., Smith D.P., Zhang X.Y., Wery J.P., Schevitz R.W. Crystal structure of the obese protein leptin-E100. Nature 1997, 387:206-209.
17. Halaas J.L., Gajiwala K.S., Maffei M., Cohen S.L., Chait B.T., Rabinowitz D., Lallone R.L., Burley S.K., Friedman J.M. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995, 269:543-546.
18. Pelleymounter M.A., Cullen M.J., Baker M.B., Hecht R., Winters D., Boone T., Collins F. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995, 269:540-543.
19. Campfield L.A., Smith F.J., Burn P. The OB protein (leptin) pathway-a link between adipose tissue mass and central neural networks. Horm. Metab. Res. 1996, 28:619-632.
20. Halaas J.L., Boozer C., Blair-West J., Fidahusein N., Denton D.A., Friedman J.M. Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc. Natl. Acad. Sci. U S A 1997, 94:8878-8883.
21. Pelleymounter M.A., Cullen M.J., Healy D., Hecht R., Winters D., McCaleb M. Efficacy of exogenous recombinant murine leptin in lean and obese 10- to 12-mo-old female CD-1 mice. Am. J. Physiol. 1998, 275:R950-R959.
22. Cusin I., Rohner-Jeanrenaud F., Stricker-Krongrad A., Jeanrenaud B. The weight-reducing effect of an intracerebroventricular bolus injection of leptin in genetically obese fa/fa rats. Reduced sensitivity compared with lean animals. Diabetes 1996, 45:1446-1450.
23. Goldstone A.P., Mercer J.G., Gunn I., Moar K.M., Edwards C.M., Rossi M., Howard J.K., Rasheed S., Turton M.D., Small C., Heath M.M., O'Shea D., Steere J., Meeran K., Ghatei M.A., Hoggard N., Bloom S.R. Leptin interacts with glucagon-like peptide-1 neurons to reduce food intake and body weight in rodents. FEBS Lett. 1997, 415:134-138.
24. Seeley R.J., van Dijk G., Campfield L.A., Smith F.J., Burn P., Nelligan J.A., Bell S.M., Baskin D.G., Woods S.C., Schwartz M.W. Intraventricular leptin reduces food intake and body weight of lean rats but not obese Zucker rats. Horm. Metab. Res. 1996, 28:664-668.
25. Brunner L., Whitebread S., Leconte I., Stricker-Krongrad A., Cumin F., Chiesi M., Levens N. A peptide leptin antagonist reduces food intake in rodents. Int J Obes Relat Metab Disord 1999, 23:463-469.
26. Elinav E., Niv-Spector L., Katz M., Price T.O., Ali M., Yacobovitz M., Solomon G., Reicher S., Lynch J.L., Halpern Z., Banks W.A., Gertler A. Pegylated leptin antagonist is a potent orexigenic agent: preparation and mechanism of activity. Endocrinology 2009, 150:3083-3091.
27. Verploegen S.A., Plaetinck G., Devos R., Van der Heyden J., Guisez Y. A human leptin mutant induces weight gain in normal mice. FEBS Lett. 1997, 405:237-240.
28. Zhang J., Matheny M.K., Tumer N., Mitchell M.K., Scarpace P.J. Leptin antagonist reveals that the normalization of caloric intake and the thermic effect of food after high-fat feeding are leptin dependent. Am J Physiol Regul Integr Comp Physiol 2007, 292:R868-R874.
29. Eckel L.A., Langhans W., Kahler A., Campfield L.A., Smith F.J., Geary N. Chronic administration of OB protein decreases food intake by selectively reducing meal size in female rats. Am. J. Physiol. 1998, 275:R186-R193.
30. Rosenbaum M., Nicolson M., Hirsch J., Heymsfield S.B., Gallagher D., Chu F., Leibel R.L. Effects of gender, body composition, and menopause on plasma concentrations of leptin. J. Clin. Endocrinol. Metab. 1996, 81:3424-3427.
31. Rosenbaum M., Pietrobelli A., Vasselli J.R., Heymsfield S.B., Leibel R.L. Sexual dimorphism in circulating leptin concentrations is not accounted for by differences in adipose tissue distribution. Int J Obes Relat Metab Disord 2001, 25:1365-1371.
32. Peelman F., Iserentant H., De Smet A.S., Vandekerckhove J., Zabeau L., Tavernier J. Mapping of binding site III in the leptin receptor and modeling of a hexameric leptin.leptin receptor complex. J. Biol. Chem. 2006, 281:15496-15504.
33. Niv-Spector L., Gonen-Berger D., Gourdou I., Biener E., Gussakovsky E.E., Benomar Y., Ramanujan K.V., Taouis M., Herman B., Callebaut I., Djiane J., Gertler A. Identification of the hydrophobic strand in the A-B loop of leptin as major binding site III: implications for large-scale preparation of potent recombinant human and ovine leptin antagonists. Biochem. J. 2005, 391:221-230.
34. Gonzalez R.R., Leavis P.C. A peptide derived from the human leptin molecule is a potent inhibitor of the leptin receptor function in rabbit endometrial cells. Endocrine 2003, 21:185-195.
35. Otvos L., Terrasi M., Cascio S., Cassone M., Abbadessa G., De Pascali F., Scolaro L., Knappe D., Stawikowski M., Cudic P., Wade J.D., Hoffmann R., Surmacz E. Development of a pharmacologically improved peptide agonist of the leptin receptor. Biochim Biophys Acta 2008, 1783:1745-1754.
36. de Oliveira V.X., Fazio M.A., Santos E.L., Pesquero J.B., Miranda A. In vitro evaluation of leptin fragments activity on the ob receptor. J. Pept. Sci. 2008, 14:617-625.
37. Gonzalez R.R., Cherfils S., Escobar M., Yoo J.H., Carino C., Styer A.K., Sullivan B.T., Sakamoto H., Olawaiye A., Serikawa T., Lynch M.P., Rueda B.R. Leptin signaling promotes the growth of mammary tumors and increases the expression of vascular endothelial growth factor (VEGF) and its receptor type two (VEGF-R2). J. Biol. Chem. 2006, 281:26320-26328.
38. Ramos M.P., Rueda B.R., Leavis P.C., Gonzalez R.R. Leptin serves as an upstream activator of an obligatory signaling cascade in the embryo-implantation process. Endocrinology 2005, 146:694-701.
39. Samson W.K., Murphy T.C., Robison D., Vargas T., Tau E., Chang J.K. A 35 amino acid fragment of leptin inhibits feeding in the rat. Endocrinology 1996, 137:5182-5185.
40. Matarese G., Leiter E.H., La Cava A. Leptin in autoimmunity: many questions, some answers. Tissue Antigens 2007, 70:87-95.
41. Matarese G., Moschos S., Mantzoros C.S. Leptin in immunology. J. Immunol. 2005, 174:3137-3142.
42. Matarese G., Procaccini C., De Rosa V. The intricate interface between immune and metabolic regulation: a role for leptin in the pathogenesis of multiple sclerosis?. J. Leukoc. Biol. 2008, 84:893-899.
43. Bokarewa M., Bokarew D., Hultgren O., Tarkowski A. Leptin consumption in the inflamed joints of patients with rheumatoid arthritis. Ann. Rheum. Dis. 2003, 62:952-956.
44. Dubey L., Hesong Z. Role of leptin in atherogenesis. Exp. Clin. Cardiol. 2006, 11:269-275.